Volume not number of metastases: Gamma Knife radiosurgery management of intracranial lesions from an Australian perspective

Michael A. Izard, Vaughan Moutrie, Jeffrey M. Rogers, Ken Beath, Michael Grace, Bianca Karle, Annie Ho, John W. Fuller

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background and purpose: To assess the response of the first cohort of patients treated with Gamma Knife radiosurgery in Australia. Materials and methods: A prospectively collected cohort of 180 patients with intracranial metastases from different primaries was treated between August 2010 and July 2017. Survival was calculated using the Kaplan–Meier's method. Cox regression was used for multivariate analysis. Results: Currently 141 patients (78.3%) have died of their disease. The median survival for the group as a whole was 9.2 months, with observed differences resulting from the volume of tumor burden (11.4 months for volumes <3.2 cm 3 to 5.16 months for volume >9.1 cm 3 ). Overall 2-year survival was 20.7%. Conclusion: Results from the first Gamma Knife radiosurgery center in Australia showed that the treatment is feasible and effective, consistent with the international experience. For patients with larger numbers of intracranial metastases, the total volume of the intracranial burden may be of more significance in predicting outcomes. While there appeared to be a difference in survival by histologic origin, this could be related to concurrent systemic immunotherapy available for certain tumors.

LanguageEnglish
Pages43-49
Number of pages7
JournalRadiotherapy and Oncology
Volume133
DOIs
Publication statusPublished - 1 Apr 2019

Fingerprint

Radiosurgery
Neoplasm Metastasis
Survival
Tumor Burden
Immunotherapy
Multivariate Analysis
Neoplasms
Therapeutics

Keywords

  • Brain metastases
  • Gamma knife surgery
  • Neurosurgery
  • Stereotactic radiosurgery
  • Stereotactic radiotherapy

Cite this

Izard, Michael A. ; Moutrie, Vaughan ; Rogers, Jeffrey M. ; Beath, Ken ; Grace, Michael ; Karle, Bianca ; Ho, Annie ; Fuller, John W. / Volume not number of metastases : Gamma Knife radiosurgery management of intracranial lesions from an Australian perspective. In: Radiotherapy and Oncology. 2019 ; Vol. 133. pp. 43-49.
@article{84907113318b4b4aa0b4f47d02e3db5e,
title = "Volume not number of metastases: Gamma Knife radiosurgery management of intracranial lesions from an Australian perspective",
abstract = "Background and purpose: To assess the response of the first cohort of patients treated with Gamma Knife radiosurgery in Australia. Materials and methods: A prospectively collected cohort of 180 patients with intracranial metastases from different primaries was treated between August 2010 and July 2017. Survival was calculated using the Kaplan–Meier's method. Cox regression was used for multivariate analysis. Results: Currently 141 patients (78.3{\%}) have died of their disease. The median survival for the group as a whole was 9.2 months, with observed differences resulting from the volume of tumor burden (11.4 months for volumes <3.2 cm 3 to 5.16 months for volume >9.1 cm 3 ). Overall 2-year survival was 20.7{\%}. Conclusion: Results from the first Gamma Knife radiosurgery center in Australia showed that the treatment is feasible and effective, consistent with the international experience. For patients with larger numbers of intracranial metastases, the total volume of the intracranial burden may be of more significance in predicting outcomes. While there appeared to be a difference in survival by histologic origin, this could be related to concurrent systemic immunotherapy available for certain tumors.",
keywords = "Brain metastases, Gamma knife surgery, Neurosurgery, Stereotactic radiosurgery, Stereotactic radiotherapy",
author = "Izard, {Michael A.} and Vaughan Moutrie and Rogers, {Jeffrey M.} and Ken Beath and Michael Grace and Bianca Karle and Annie Ho and Fuller, {John W.}",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.radonc.2018.12.018",
language = "English",
volume = "133",
pages = "43--49",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier",

}

Volume not number of metastases : Gamma Knife radiosurgery management of intracranial lesions from an Australian perspective. / Izard, Michael A.; Moutrie, Vaughan; Rogers, Jeffrey M.; Beath, Ken; Grace, Michael; Karle, Bianca; Ho, Annie; Fuller, John W.

In: Radiotherapy and Oncology, Vol. 133, 01.04.2019, p. 43-49.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Volume not number of metastases

T2 - Radiotherapy and Oncology

AU - Izard, Michael A.

AU - Moutrie, Vaughan

AU - Rogers, Jeffrey M.

AU - Beath, Ken

AU - Grace, Michael

AU - Karle, Bianca

AU - Ho, Annie

AU - Fuller, John W.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Background and purpose: To assess the response of the first cohort of patients treated with Gamma Knife radiosurgery in Australia. Materials and methods: A prospectively collected cohort of 180 patients with intracranial metastases from different primaries was treated between August 2010 and July 2017. Survival was calculated using the Kaplan–Meier's method. Cox regression was used for multivariate analysis. Results: Currently 141 patients (78.3%) have died of their disease. The median survival for the group as a whole was 9.2 months, with observed differences resulting from the volume of tumor burden (11.4 months for volumes <3.2 cm 3 to 5.16 months for volume >9.1 cm 3 ). Overall 2-year survival was 20.7%. Conclusion: Results from the first Gamma Knife radiosurgery center in Australia showed that the treatment is feasible and effective, consistent with the international experience. For patients with larger numbers of intracranial metastases, the total volume of the intracranial burden may be of more significance in predicting outcomes. While there appeared to be a difference in survival by histologic origin, this could be related to concurrent systemic immunotherapy available for certain tumors.

AB - Background and purpose: To assess the response of the first cohort of patients treated with Gamma Knife radiosurgery in Australia. Materials and methods: A prospectively collected cohort of 180 patients with intracranial metastases from different primaries was treated between August 2010 and July 2017. Survival was calculated using the Kaplan–Meier's method. Cox regression was used for multivariate analysis. Results: Currently 141 patients (78.3%) have died of their disease. The median survival for the group as a whole was 9.2 months, with observed differences resulting from the volume of tumor burden (11.4 months for volumes <3.2 cm 3 to 5.16 months for volume >9.1 cm 3 ). Overall 2-year survival was 20.7%. Conclusion: Results from the first Gamma Knife radiosurgery center in Australia showed that the treatment is feasible and effective, consistent with the international experience. For patients with larger numbers of intracranial metastases, the total volume of the intracranial burden may be of more significance in predicting outcomes. While there appeared to be a difference in survival by histologic origin, this could be related to concurrent systemic immunotherapy available for certain tumors.

KW - Brain metastases

KW - Gamma knife surgery

KW - Neurosurgery

KW - Stereotactic radiosurgery

KW - Stereotactic radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85059864115&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2018.12.018

DO - 10.1016/j.radonc.2018.12.018

M3 - Article

VL - 133

SP - 43

EP - 49

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

ER -